Disease Info Card

Placental Choriocarcinoma

Information about Placental Choriocarcinoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Placental Choriocarcinoma

Most recent studies have shown that Placental Choriocarcinoma shares some biological mechanisms with carcinoma, cholera, choriocarcinoma, fetal-death, gestational-choriocarcinoma, hemorrhage, liver-neoplasms, lung-neoplasms, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, metastatic-malignant-neoplasm-to-the-lung, neoplasm-metastasis, neoplasms, persistent-fetal-circulation-syndrome, placenta-disorders, pregnancy-complications, pregnancy-complications-neoplastic, sarcoma, uterine-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Placental Choriocarcinoma, and have been seen in publications frequently: Amino Acid Transport, Anion Transport, Carnitine Transport, Cell Death, Cell Proliferation, Endocytosis, Fatty Acid Transport, Glycine Transport, Iodide Transport, Localization, Neutral Amino Acid Transport, Parturition, Pathogenesis, Receptor-mediated Endocytosis, Reverse Transcription, Secretion, Serotonin Transport, Serotonin Uptake, Taurine Transport, Transport

Quite a number of genes have been found to play important roles in Placental Choriocarcinoma, such as ABCG2, CALM1, CALM2, CALM3, CYP19A1, JAK2, JUN, LEP, MAPK1, MAPK3, MGAT1, PLIN2, POU2F1, PPARG, SLC1A5, SLC6A2, SLC6A4, SLC6A5, SLC6A9. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.